Optimizing exercise testing-based risk stratification to predict poor prognosis after acute heart failure.
Shyh-Ming ChenPo-Jui WuLin-Yi WangChin-Ling WeiCheng-I ChengHsiu-Yu FangYen-Nan FangYung-Lung ChenDavid Kwan-Ru HuangFan-Yen LeeMien-Cheng ChenPublished in: ESC heart failure (2022)
is required in the current GDMT era for advanced HF therapy. Other clinical factors such as ICD use, hyponatraemia, and chronic kidney disease could also be used to predict poor prognosis. The improvement of resource allocation and patient outcomes could be achieved by careful selection of appropriate patients for advanced HF therapies, such as cardiac transplantation.